Login / Signup

CXCL14 as a potential marker for immunotherapy response prediction in renal cell carcinoma.

Qiwen PanRuiqi LiuXinyue ZhangLingling CaiYilin LiPei DongJianming GaoYang LiuLiru He
Published in: Therapeutic advances in medical oncology (2023)
CXCL14 expression is associated with immunotherapy response in RCC. It is a promising biomarker for immunotherapy response prediction and may be an effective epigenetic modulator in combination with immunotherapy approaches.
Keyphrases
  • renal cell carcinoma
  • gene expression
  • poor prognosis
  • risk assessment
  • climate change
  • human health